Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Annual Information Update

27 May 2009 07:00

RNS Number : 8390S
PuriCore Plc
27 May 2009
 



PuriCore plc

Annual Information Update

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 27 May 2009 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, sets out below a list of the information that has been published or made available to the public over the previous 12 months, up to and including 27 May 2009.

The Company announces that, in accordance with Rule 5.2 of the Prospectus Rules, the following information was published or made available to the public during the 12-month period between 27 May 2008 and 27 May 2009. In accordance with Prospectus Rule 5.2.7, it is acknowledged that whilst the information referred to above was up to date at the time of publication, such disclosures may, at any time, become out of date due to changing circumstances. For the purposes of this update, the information is referred to rather than provided in full. Full copies of each item can be found in the locations specified below. 

 

1. Announcements made via the Regulatory Information Service

Allthe announcements listed below can be obtained from the London Stock Exchange website, www.londonstockexchange.com/marketnews or from the Company's website, www.puricore.com

Date

Headline

30/04/2009

PuriCore Plc - Holding(s) in Company

28/04/2009

PuriCore Plc - Q1 Interim Management Statement

28/04/2009

PuriCore Plc - Final Results

17/02/2009

PuriCore Plc - Holding(s) in Company

10/02/2009

PuriCore Plc - Director/PDMR Shareholding

09/02/2009

PuriCore Plc - Director/PDMR Shareholding

06/02/2009

PuriCore Plc - Holding(s) in Company

04/02/2009

PuriCore Plc - Blocklisting Six Monthly Return

03/02/2009

PuriCore Plc - Director/PDMR Shareholding

02/02/2009

PuriCore Plc - Trading Statement

02/01/2009

PuriCore Plc - Director/PDMR Shareholding

29/12/2008

PuriCore Plc - Director/PDMR Shareholding

12/11/2008

PuriCore Plc - Director/PDMR Shareholding

03/11/2008

PuriCore Plc - Notification of PDMR Interest - Option Award

24/10/2008

PuriCore Plc - Receives an order from Safeway

13/10/2008

PuriCore Plc - Board and Organisational Changes

13/10/2008

PuriCore Plc - Interim Management Statement

01/10/2008

PuriCore Plc - Raises $9.74 million

11/09/2008

PuriCore Plc - Holding(s) in Company

04/09/2008

PuriCore Plc - Holding(s) in Company

03/09/2008

PuriCore Plc - Holding(s) in Company

03/09/2008

PuriCore Plc - PDMR Dealings

29/08/2008

PuriCore Plc - Total Voting Rights

29/08/2008

PuriCore Plc - Interim Results

26/08/2008

PuriCore Plc - Result of General Meeting

22/08/2008

PuriCore Plc - Result of Open Offer

04/08/2008

PuriCore Plc - Blocklisting Six Monthly Return

30/07/2008

PuriCore Plc - PuriCore Wins Food Safety Contract

30/07/2008

PuriCore Plc - Trading Update

30/07/2008

PuriCore Plc - Placing and Open Offer

02/07/2008

PuriCore Plc - Awarded Contract

01/07/2008

PuriCore Plc - Patent Decision and Debt Financing

26/06/2008

PuriCore Plc - AGM Statement

19/06/2008

PuriCore Plc - Piper Jaffray European Conference

09/06/2008

PuriCore Plc - Natural Resources & Infrastructure Conference

02/06/2008

PuriCore Plc - Annual Report and Accounts

 

2. Documents filed at Companies House

Copies of these documents can be obtained from Companies House at Crown Way, Maindy, Cardiff CF14 3UZ or from Companies House website www.companieshouse.co.uk.

Date

Document

Description

12/05/2009

363a

Annual Return

12/05/2009

288c

Change in Details of Director

12/05/2009

288c

Change in Details of Director

20/01/2009

353a

 Location of Register of Members 

06/11/2008 

288b

Terminating Appointment of Director

02/10/2008 

288b

Terminating Appointment of Director

02/10/2008 

288b

Terminating Appointment of Director

18/09/2008 

RES04

Written Resolutions

10/09/2008 

122

Notice regarding shares

04/08/2008 

AA

Group of Companies' Accounts 

23/07/2008 

RES01

Resolutions

14/07/2008 

Mem/Arts

Articles of Association 

27/05/2008 

363a

Annual Return

27/05/2008 

353

Location of Register of Members

21/05/2008 

88(2)

Return of Allotment of Shares 

 

3. Documents published and sent to shareholders 

Date

Document Description

02/06/2008

Annual Report and Accounts 2007, Proxy Form, and Notice of Annual General Meeting

04/08/2008

Placing and Open Offer Prospectus, Application, and Proxy Form

11/05/2009

Annual Report and Accounts 2008, Proxy Form, and Notice of Annual General Meeting

 

4. Documents filed with the UKLA Documents Viewing Facility

Date

Document Description

05/05/2009

Annual Report and Accounts 2008

29/08/2008

Half-Yearly Report 2008

04/08/2008

Placing and Open Offer Prospectus

03/06/2008

Annual Report and Accounts 2007

Copies of these documents can be obtained from:

 

Registered Office

PuriCore plc

58 Davies Street

London

W1K5JF

UK

 

Andrea Holtzman Drucker

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUDGGZKKVNGLZM
Date   Source Headline
9th Oct 20185:02 pmRNSForm 8.3 - Realm Therapeutics PLC
9th Oct 201810:13 amRNSForm 8.3 - Realm Therapeutics plc
5th Oct 20186:08 pmBUSForm 8.3 - Realm Therapeutics PLC
5th Oct 20182:00 pmRNSFORM 8.3 - Realm Therapeutics Plc
4th Oct 20188:57 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics plc
2nd Oct 201810:43 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics PLC
1st Oct 20187:00 amRNSProvides Update on Timing of Formal Sale Process
24th Sep 20189:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Sep 201811:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20183:16 pmRNSHolding(s) in Company
20th Sep 201811:53 amRNSForm 8.3 - REALM THERAPEUTICS PLC
20th Sep 201811:18 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Sep 20184:31 pmRNSForm 8 (OPD) - Realm Therapeutics plc
19th Sep 201811:11 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
18th Sep 201811:19 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
17th Sep 20187:00 amRNSCorporate Update and Hiring of Advisor
20th Aug 201811:00 amRNSPrice Monitoring Extension
20th Aug 20187:00 amRNSBlock listing Interim Review
15th Aug 20184:35 pmRNSPrice Monitoring Extension
14th Aug 20187:10 amRNSHalf-year Report
8th Aug 20187:00 amRNSPresents at Wedbush PacGrow Healthcare Conference
7th Aug 20187:00 amRNSNotice of Results
16th Jul 20185:33 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPre-Clinical Study in Atopic Dermatitis
4th Jul 20187:00 amRNSInstructions for Exchanging Ordinary Shares
4th Jul 20187:00 amRNSSEC registration effective NASDAQ listing approved
14th Jun 201810:54 amRNSResult of AGM
31st May 20187:00 amRNSRealm to Present at June Investor Conferences
24th May 20187:00 amRNSEnrollment complete for Phase 2 study of PR022
23rd May 20187:00 amRNSFiling with US SEC to Facilitate Nasdaq Listing
21st May 20187:00 amRNSData Presentation at IID 2018
2nd May 201812:39 pmRNSAnnual Financial Report Available
2nd May 20187:00 amRNSFinal Results
2nd May 20187:00 amRNSRealm Files Registration for Nasdaq Listing of ADS
26th Apr 20182:32 pmRNSNotice of Results
12th Mar 20184:40 pmRNSSecond Price Monitoring Extn
12th Mar 20184:35 pmRNSPrice Monitoring Extension
12th Mar 20187:00 amRNSClinical Update including PR013 Phase II results
8th Mar 20187:00 amRNSPresenting at Cowen Healthcare Conference
27th Feb 20187:00 amRNSPatent portfolio strengthened with USPTO allowance
20th Feb 201812:00 pmRNSPresentation at RBC Healthcare Conference
16th Feb 20187:00 amRNSBlock listing Interim Review
15th Feb 20187:00 amRNSClinical and Business Update
2nd Jan 20187:00 amRNSPresents at 5th Annual Dermatology Summit
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR013
5th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.